Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCH Treatment for Cellulite (MRI and Histopathology Study)
NCT04209530Phase 2Terminated
- Sponsor
- Endo International plc
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Nov 2019; status: terminated.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT04209530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04209530.